Titelia

Holdings of a16z Capital Management, L.L.C.

16 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 96 % of the equity sleeve

Sector breakdown

  • Communication 9.4 %
  • Financials 4.7 %
  • Unattributed 85.8 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 100.0 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US161.3B $100.00 %

Positions

RankCompanySharesValueWeight
1Navan Inc 28,218,676373.6M $
2Figma Inc 16,011,378338.5M $
3Meta Platforms Inc 212,531121.6M $
4Revolution Medicines Inc 921,09989.6M $
5Nautilus Biotechnology Inc 17,653,91768.5M $
6Block Inc 1,016,69761.2M $
7BioAge Labs Inc 3,233,17056.5M $
8Maze Therapeutics Inc 1,702,22550.8M $
9Erasca Inc 2,862,50046.3M $
10DAMORA THERAPEUTICS INC 1,236,15732M $
11Omada Health Inc 2,307,28429M $
12CAMP4 THERAPEUTICS CORP 2,125,3399.4M $
13Aktis Oncology Inc 415,0007.4M $
14Bitgo Holdings Inc 666,3565.5M $
15Ginkgo Bioworks Holdings Inc 108,568665.5K $
16IP STRATEGY HOLDINGS INC 82,74021.8K $